Category Tag

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that it is developing a new strategy to provide its direction, mission, values and focus through to 2030. What should we expect?

It's been a challenging few weeks for the UK life sciences sector. Following the breakdown of the talks with the Government to provide a more competitive reimbursement scheme for pharma, there have been a number of high-profile decisions that have created big concerns for the future of the sector. However, there have been some good news stories too, including a resilient message from MedCity - the life sciences arm of London and Partners, with whom VWV is a partner.

Provisions in non-disclosure agreements that prevent victims of criminal conduct from sharing information with certain people are now void under new legislation.

Reports suggest the government is considering reintroducing modest fees for employment tribunal and appeal claims, though no decision has yet been made.

The Home Secretary has confirmed plans to increase the qualifying period for indefinite leave to remain from five to ten years, with new eligibility criteria set for consultation.

The Employment Appeal Tribunal has provided clarity on how commission schemes operate, highlighting the importance of well-drafted commission clauses and clear rules on apportioning team effort.